S5U4R2 (S5U4R2_YARLL) Yarrowia lipolytica (Candida lipolytica)

Cytochrome b UniProtKBAFDB90v4InterProInteractive Modelling

385 aa; Sequence (Fasta) ; 1 identical sequence: Yarrowia lipolytica: Q9B6D0

Available Structures

18 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Complex III2 from Yarrowia lipolytica, combined datasets, consensus refinement
8ab6
 Heteromer
Q6C0H4; Q6C2E3; Q6C387; Q6C3K7; Q6CC60; Q6CG23; Q6CGP7; Q6CGY9; Q6CI02; Q9B6D0; 		1-383
4×HEM; 4×PC1; 4×PTY; 10×CDL; 4×LMT; 2×XP4; 2×HEC;
Assess
Complex III2 from Yarrowia lipolytica, with decylubiquinol and antimycin A, consensus refinement
8abl
 Heteromer
Q6C0H4; Q6C2E3; Q6C387; Q6C3K7; Q6CC60; Q6CG23; Q6CGP7; Q6CGY9; Q6CI02; Q9B6D0; 		1-383
4×HEM; 4×PC1; 4×PTY; 10×CDL; 4×LMT; 2×AWB; 2×XP4; 2×HEC;
Assess
Complex III2 from Yarrowia lipolytica, oxidised with ferricyanide, int-position
8abf
 Heteromer
Q6C0H4; Q6C2E3; Q6C387; Q6C3K7; Q6CC60; Q6CG23; Q6CGP7; Q6CGY9; Q6CI02; Q9B6D0; 		1-383
4×HEM; 4×PC1; 4×PTY; 10×CDL; 4×LMT; 1×FES; 2×HEC; 2×XP4;
Assess
Complex III2 from Yarrowia lipolytica, oxidised with ferricyanide, c-position
8abg
 Heteromer
Q6C0H4; Q6C2E3; Q6C387; Q6C3K7; Q6CC60; Q6CG23; Q6CGP7; Q6CGY9; Q6CI02; Q9B6D0; 		1-383
4×HEM; 4×PC1; 4×PTY; 10×CDL; 4×LMT; 1×FES; 2×XP4; 2×HEC;
Assess
Complex III2 from Yarrowia lipolytica, oxidised with ferricyanide, b-position
8abe
 Heteromer
Q6C0H4; Q6C2E3; Q6C387; Q6C3K7; Q6CC60; Q6CG23; Q6CGP7; Q6CGY9; Q6CI02; Q9B6D0; 		1-383
4×HEM; 4×PC1; 4×PTY; 10×CDL; 4×LMT; 1×FES; 2×XP4; 2×HEC;
Assess
Complex III2 from Yarrowia lipolytica, decylubiquinol bound, b-position
8abk
 Heteromer
Q6C0H4; Q6C2E3; Q6C387; Q6C3K7; Q6CC60; Q6CG23; Q6CGP7; Q6CGY9; Q6CI02; Q9B6D0; 		1-383
4×HEM; 4×PC1; 4×PTY; 10×CDL; 2×DCQ; 4×LMT; 1×FES; 2×XP4; 2×HEC;
Assess
Complex III2, b-position, with decylubiquinone and ascorbate-reduced
8ab8
 Heteromer
Q6C0H4; Q6C2E3; Q6C387; Q6C3K7; Q6CC60; Q6CG23; Q6CGP7; Q6CGY9; Q6CI02; Q9B6D0; 		1-383
4×HEM; 4×PC1; 4×PTY; 10×CDL; 4×LMT; 1×DCQ; 1×FES; 2×XP4; 2×HEC;
Assess
Complex III2 from Yarrowia lipolytica, apo, c-position
8ac4
 Heteromer
Q6C0H4; Q6C2E3; Q6C387; Q6C3K7; Q6CC60; Q6CG23; Q6CGP7; Q6CGY9; Q6CI02; Q9B6D0; 		1-383
4×HEM; 4×PC1; 4×PTY; 10×CDL; 4×LMT; 1×FES; 2×XP4; 2×HEC;
Assess
Complex III2 from Yarrowia lipolytica, apo, int-position
8ac3
 Heteromer
Q6C0H4; Q6C2E3; Q6C387; Q6C3K7; Q6CC60; Q6CG23; Q6CGP7; Q6CGY9; Q6CI02; Q9B6D0; 		1-383
4×HEM; 4×PC1; 4×PTY; 10×CDL; 4×LMT; 1×FES; 2×XP4; 2×HEC;
Assess
Complex III2 from Yarrowia lipolytica, apo, b-position
8abm
 Heteromer
Q6C0H4; Q6C2E3; Q6C387; Q6C3K7; Q6CC60; Q6CG23; Q6CGP7; Q6CGY9; Q6CI02; Q9B6D0; 		1-383
4×HEM; 4×PC1; 4×PTY; 10×CDL; 4×LMT; 1×FES; 2×XP4; 2×HEC;
Assess
Complex III2 from Yarrowia lipolytica, antimycin A bound, b-position
8abh
 Heteromer
Q6C0H4; Q6C2E3; Q6C387; Q6C3K7; Q6CC60; Q6CG23; Q6CGP7; Q6CGY9; Q6CI02; Q9B6D0; 		1-383
4×HEM; 4×PC1; 4×PTY; 10×CDL; 2×AWB; 1×FES; 2×LMT; 2×XP4; 2×HEC;
Assess
Complex III2 from Yarrowia lipolytica,antimycin A bound, int-position
8abi
 Heteromer
Q6C0H4; Q6C2E3; Q6C387; Q6C3K7; Q6CC60; Q6CG23; Q6CGP7; Q6CGY9; Q6CI02; Q9B6D0; 		1-383
4×HEM; 4×PC1; 4×PTY; 10×CDL; 2×AWB; 1×FES; 2×LMT; 2×XP4; 2×HEC;
Assess
Complex III2 from Yarrowia lipolytica, with decylubiquinol, oxidised, b-position
8ac5
 Heteromer
Q6C0H4; Q6C2E3; Q6C387; Q6C3K7; Q6CC60; Q6CG23; Q6CGP7; Q6CGY9; Q6CI02; Q9B6D0; 		1-383
6×HEC; 4×PC1; 4×PTY; 10×CDL; 4×LMT; 1×FES; 2×XP4;
Assess
Complex III2 from Yarrowia lipolytica, ascorbate-reduced, int-position
8aba
 Heteromer
Q6C0H4; Q6C2E3; Q6C387; Q6C3K7; Q6CC60; Q6CG23; Q6CGP7; Q6CGY9; Q6CI02; Q9B6D0; 		1-383
4×HEM; 4×PC1; 4×PTY; 10×CDL; 4×LMT; 1×FES; 2×HEC; 2×XP4;
Assess
Complex III2 from Yarrowia lipolytica, ascorbate-reduced, c-position
8abb
 Heteromer
Q6C0H4; Q6C2E3; Q6C387; Q6C3K7; Q6CC60; Q6CG23; Q6CGP7; Q6CGY9; Q6CI02; Q9B6D0; 		1-383
4×HEM; 4×PC1; 4×PTY; 10×CDL; 4×LMT; 1×FES; 2×XP4; 2×HEC;
Assess
Complex III2 from Yarrowia lipolytica, ascorbate-reduced, b-position
8ab9
 Heteromer
Q6C0H4; Q6C2E3; Q6C387; Q6C3K7; Q6CC60; Q6CG23; Q6CGP7; Q6CGY9; Q6CI02; Q9B6D0; 		1-383
4×HEM; 4×PC1; 4×PTY; 10×CDL; 4×LMT; 1×FES; 2×XP4; 2×HEC;
Assess
Complex III2 from Yarrowia lipolytica, atovaquone and antimycin A bound
8ab7
 Heteromer
Q6C0H4; Q6C2E3; Q6C387; Q6C3K7; Q6CC60; Q6CG23; Q6CGP7; Q6CGY9; Q6CI02; Q9B6D0; 		1-383
4×HEM; 4×PC1; 4×PTY; 10×CDL; 4×LMT; 2×AWB; 2×AOQ; 2×FES; 2×XP4; 2×HEC;
Assess
Complex III2 from Yarrowia lipolytica, antimycin A bound, c-position
8abj
 Heteromer
Q6C0H4; Q6C2E3; Q6C387; Q6C3K7; Q6CC60; Q6CG23; Q6CGP7; Q6CGY9; Q6CI02; Q9B6D0; 		1-383
4×HEM; 4×PC1; 4×PTY; 10×CDL; 2×AWB; 1×FES; 2×LMT; 2×XP4; 2×HEC;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8ab6.1.Amonomer0.751-383
2×HEM;100.00
Assess